Literature DB >> 12413866

1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptor.

John W Huffman1, Simon M Bushell, John R A Miller, Jenny L Wiley, Billy R Martin.   

Abstract

Three series of new cannabinoids were prepared and their affinities for the CB(1) and CB(2) cannabinoid recptors were determined. These are the 1-methoxy-3-(1',1'-dimethylalkyl)-, 1-deoxy-11-hydroxy-3-(1',1'-dimethylalkyl)- and 11-hydroxy-1-methoxy-3-(1',1'-dimethylalkyl)-Delta(8)-tetrahydrocannabinols, which contain alkyl chains from dimethylethyl to dimethylheptyl appended to C-3 of the cannabinoid. All of these compounds have greater affinity for the CB(2) receptor than for the CB(1) receptor, however only 1-methoxy-3-(1',1'-dimethylhexyl)-Delta(8)-THC (JWH-229, 6e) has effectively no affinity for the CB(1) receptor (K(i)=3134+/-110nM) and high affinity for CB(2) (K(i)=18+/-2nM).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12413866     DOI: 10.1016/s0968-0896(02)00331-0

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

Review 1.  Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands.

Authors:  A Poso; J W Huffman
Journal:  Br J Pharmacol       Date:  2007-11-05       Impact factor: 8.739

2.  Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940.

Authors:  John W Huffman; Alicia L S Thompson; Jenny L Wiley; Billy R Martin
Journal:  Bioorg Med Chem       Date:  2007-09-22       Impact factor: 3.641

3.  Synthesis and pharmacology of 1-methoxy analogs of CP-47,497.

Authors:  John W Huffman; Seon A Hepburn; Patricia H Reggio; Dow P Hurst; Jenny L Wiley; Billy R Martin
Journal:  Bioorg Med Chem       Date:  2010-06-22       Impact factor: 3.641

4.  Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.

Authors:  María Gómez-Cañas; Gemma Navarro; Paula Morales; Dow P Hurst; Francisco J Carrillo-Salinas; Laura Lagartera; Ruth Pazos; Pilar Goya; Patricia H Reggio; Carmen Guaza; Rafael Franco; Javier Fernández-Ruiz; Nadine Jagerovic
Journal:  J Med Chem       Date:  2016-07-06       Impact factor: 7.446

Review 5.  Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Authors:  Vamsi Reddy; Dayton Grogan; Meenakshi Ahluwalia; Évila Lopes Salles; Pankaj Ahluwalia; Hesam Khodadadi; Katelyn Alverson; Andy Nguyen; Srikrishnan P Raju; Pankaj Gaur; Molly Braun; Fernando L Vale; Vincenzo Costigliola; Krishnan Dhandapani; Babak Baban; Kumar Vaibhav
Journal:  EPMA J       Date:  2020-04-15       Impact factor: 6.543

6.  Fluorinated cannabinoid CB2 receptor ligands: synthesis and in vitro binding characteristics of 2-oxoquinoline derivatives.

Authors:  Nashaat Turkman; Aleksander Shavrin; Roman A Ivanov; Brian Rabinovich; Andrei Volgin; Juri G Gelovani; Mian M Alauddin
Journal:  Bioorg Med Chem       Date:  2011-08-05       Impact factor: 3.641

7.  1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor.

Authors:  John W Huffman; Seon A Hepburn; Nataliya Lyutenko; Alicia L S Thompson; Jenny L Wiley; Dana E Selley; Billy R Martin
Journal:  Bioorg Med Chem       Date:  2010-09-29       Impact factor: 3.641

Review 8.  Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.

Authors:  Patricia H Reggio
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 9.  The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids-A Systematic Review.

Authors:  Koby Cohen; Aviv Weinstein
Journal:  Brain Sci       Date:  2018-02-27

Review 10.  Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective.

Authors:  Koby Cohen; Aviv M Weinstein
Journal:  Front Public Health       Date:  2018-06-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.